Yoshimitsu Katakuse

Title: Innovations of Yoshimitsu Katakuse

Introduction

Yoshimitsu Katakuse is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medical technology, particularly in the area of boron neutron capture therapy. His innovative work has the potential to improve treatment options for patients undergoing this type of therapy.

Latest Patents

Yoshimitsu Katakuse holds a patent for an injection solution containing p-boronophenylalanine. The objective of this invention is to provide an effective injection solution for boron neutron capture therapy. The solution includes p-boronophenylalanine or a pharmaceutically acceptable salt thereof, with a boron atom ratio of 75% or more. Additionally, it contains a sugar alcohol, an antioxidant, and water, with a pH of 6.5 to 7.8 and an osmotic pressure ratio of 1.0 to 1.8. This injection solution is designed to be administered by intravenous drip injection.

Career Highlights

Yoshimitsu Katakuse is associated with Stella Pharma Corporation, where he continues to work on innovative solutions in the medical field. His dedication to research and development has led to advancements that could significantly impact patient care.

Collaborations

Yoshimitsu has collaborated with notable colleagues such as Yoshiya Iguchi and Hideki Nakashima. Their combined expertise contributes to the ongoing success of their projects and innovations.

Conclusion

Yoshimitsu Katakuse's work exemplifies the spirit of innovation in the medical field. His contributions, particularly in boron neutron capture therapy, highlight the importance of research and collaboration in advancing healthcare solutions.